YUHSpace

BROWSE

Export

Cited 8 times in

Comparable Efficacy Between Ongoing Versus Initiation of Antiviral Therapy at Treatment for HBV-related Hepatocellular Carcinoma

DC Field Value Language
dc.contributor.author김승업-
dc.contributor.author김범경-
dc.contributor.author노윤호-
dc.date.accessioned2022-12-22T03:07:05Z-
dc.date.available2022-12-22T03:07:05Z-
dc.date.issued2022-08-
dc.identifier.issn1542-3565-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/191796-
dc.description.abstractSuppression of hepatitis B virus (HBV) replication with antiviral therapy (AVT) using nucleos(t)ide analogs reduces the risk of hepatocellular carcinoma (HCC) recurrence and prolongs survival after curative treatment.1-5 Studies of the association between timing of AVT initiation and prognosis of patients with HCC receiving curative treatment are scarce. In the present study, we compared the therapeutic benefit of AVT, commenced before vs after curative treatment of HBV-related HCC, on long-term prognosis.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherW.B. Saunders-
dc.relation.isPartOfCLINICAL GASTROENTEROLOGY AND HEPATOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAntiviral Agents / therapeutic use-
dc.subject.MESHCarcinoma, Hepatocellular* / pathology-
dc.subject.MESHHepatitis B virus-
dc.subject.MESHHepatitis B, Chronic* / complications-
dc.subject.MESHHepatitis B, Chronic* / drug therapy-
dc.subject.MESHHumans-
dc.subject.MESHLiver Neoplasms* / pathology-
dc.subject.MESHPrognosis-
dc.titleComparable Efficacy Between Ongoing Versus Initiation of Antiviral Therapy at Treatment for HBV-related Hepatocellular Carcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorMi Na Kim-
dc.contributor.googleauthorBeom Kyung Kim-
dc.contributor.googleauthorYun Ho Roh-
dc.contributor.googleauthorNa Ryung Choi-
dc.contributor.googleauthorSu Jong Yu-
dc.contributor.googleauthorSeung Up Kim-
dc.identifier.doi10.1016/j.cgh.2022.02.014-
dc.contributor.localIdA00654-
dc.contributor.localIdA00487-
dc.relation.journalcodeJ02981-
dc.identifier.eissn1542-7714-
dc.identifier.pmid35181566-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S1542356522001409?via%3Dihub-
dc.contributor.alternativeNameKim, Seung Up-
dc.contributor.affiliatedAuthor김승업-
dc.contributor.affiliatedAuthor김범경-
dc.citation.volume20-
dc.citation.number8-
dc.citation.startPage1877-
dc.citation.endPage1880-
dc.identifier.bibliographicCitationCLINICAL GASTROENTEROLOGY AND HEPATOLOGY, Vol.20(8) : 1877-1880, 2022-08-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Show simple item record

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links